RANI MEXC RealStocks
Own real RANI shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-13 05:46:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Rani Therapeutics Holdings, Inc. (RANI) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $0.53, with a market capitalization of $64.65M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.51 to $2.16. This page covers its latest market performance, valuation, price trends and company information.
$64.65M | |
$0.56 | |
$0.64 | |
$0.52 | |
$0.57 | |
702.48K | |
586.48K | |
-- | |
$2.15 | |
$0.51 | |
-- | |
-- |
Rani Therapeutics Holdings, Inc. (RANI) last closed at $0.53 as of 2026-11-13 00:57:00, down 7.04% ($0.04) from the previous close of $0.57.
During the latest regular trading session, RANI traded between $0.52 and $0.64, with a volume of 702.48K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, Rani Therapeutics Holdings, Inc. (RANI) moved from $0.56 to $0.53, representing a decline of 5.00% ($0.03).
The stock traded between $0.51 and $0.64 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 478.01 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 1.1%
RANI is currently trading at $0.53, placing it 1.1% of the way from its 52-week low of $0.51 to its 52-week high of $2.16. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 69 |
| Exchange | NASDAQ |
| Company Website |
View the latest dividend and stock split events for Rani Therapeutics Holdings, Inc.
Dividend | |
|---|---|
| Ex-Dividend Date | -- |
| Payment Date | -- |
| Dividend Per Share | -- |
Stock Split | |
|---|---|
| Split Date | -- |
| Split Ratio | -- |
Eligible investors can buy real shares of Rani Therapeutics Holdings, Inc. (RANI) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to RANI, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between RANI shares and USD.
RANI Shares to USD
1.00 RANI shares = 0.528 USD
Calculations are estimates based on the latest available price and are for reference only.